Skip to main content
. 2022 Apr 27;377:e070230. doi: 10.1136/bmj-2022-070230

Table 1.

Personal characteristics of field test sample. Values are numbers (percentages) of participants unless stated otherwise

Characteristics Respondents (n=274)
Age (years):
 Mean (SD)*; range 45.0 (10.0); 21-70
Sex:
 Female 240 (88)
 Male 34 (12)
Ethnicity:
 White 253 (92)
 Asian or Asian British 7 (3)
 Black, African, Caribbean, or black British 3 (1)
 Mixed or multiple ethnic groups 11 (4)
 Other ethnic group 0 (0)
Occupational status:
 Employed full time 114 (42)
 Employed but currently not working 51 (19)
 Employed part time 39 (14)
 Furloughed 7 (3)
 Retired 6 (2)
 Caregiver 3 (1)
 In full time education 3 (1)
 Voluntary work 3 (1)
 Unemployed 20 (7)
 Other 28 (10)
Month and year of SARS-Co-V-2 infection:
 December 2019 3 (1)
 January-December 2020 233 (85)
 January-May 2021 38 (14)
Positive PCR test result for SARS-Co-V-2 infection†:
 Yes 129 (47)
 No 137 (50)
 Do not know 8 (3)
Positive lateral flow test result for SARS-Co-V-2 infection†:
 Yes 22 (8)
 No 227 (83)
Do not know 25 (9)
Admitted to hospital for SAR-Co-V-2 infection:
 Yes 11 (4)
 No 263 (96)
Admitted to ICU for SARS-Co-V-2 infection:
 Yes 0 (0)
 No 274 (100)
Attended hospital emergency department for SARS-Co-V-2 infection:
 Yes 111 (41)
 No 163 (59)
Vaccine status:
 Two doses 187 (68)
 One dose 70 (25)
 No dose 17 (6)
Received shielding letter from UK government‡:
 Yes 12 (4)
 No 262 (96)
Care home resident:
 Yes 3 (1)
 No 271 (99)
Mean (SD) EQ-5D-5L utility score 0.490 (0.253)

SD=standard deviation; PCR=polymerase chain reaction; ICU=intensive care unit; EQ-5D-5L=health related quality of life instrument.

*

n=263 respondents.

Owing to difficulties accessing PCR and lateral flow tests in the early weeks of the pandemic, not all participants had access to testing.

Letter to indicate clinical vulnerability requiring enhanced social distancing.